NO20005299L - Composition containing polyacrylate, polyterpene, nitroglycerine and optional polyvinyl acetate - Google Patents

Composition containing polyacrylate, polyterpene, nitroglycerine and optional polyvinyl acetate

Info

Publication number
NO20005299L
NO20005299L NO20005299A NO20005299A NO20005299L NO 20005299 L NO20005299 L NO 20005299L NO 20005299 A NO20005299 A NO 20005299A NO 20005299 A NO20005299 A NO 20005299A NO 20005299 L NO20005299 L NO 20005299L
Authority
NO
Norway
Prior art keywords
polyterpene
nitroglycerine
composition containing
polyvinyl acetate
containing polyacrylate
Prior art date
Application number
NO20005299A
Other languages
Norwegian (no)
Other versions
NO20005299D0 (en
Inventor
Walter Mueller
Achim Berthold
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO20005299D0 publication Critical patent/NO20005299D0/en
Publication of NO20005299L publication Critical patent/NO20005299L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

En sammensetning for påføring på huden er kjennetegnet ved at den inneholder a) en akrylat-copolymer som inneholder 25 - 40 vekt-% metylakrylat, 50-70 vekt-% 2-etylheksylakrylat, 1-10 vekt-% akrylsyre, b) et polyterpen, c) nitroglyserin kan brukes til profylakse eller behandling av koronar hjertesykdom.A composition for application to the skin is characterized in that it contains a) an acrylate copolymer containing 25-40 wt% methyl acrylate, 50-70 wt% 2-ethylhexyl acrylate, 1-10 wt% acrylic acid, b) a polyterpene , c) nitroglycerin can be used for the prophylaxis or treatment of coronary heart disease.

NO20005299A 1998-04-28 2000-10-20 Composition containing polyacrylate, polyterpene, nitroglycerine and optional polyvinyl acetate NO20005299L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19818955A DE19818955C2 (en) 1998-04-28 1998-04-28 Composition containing polyacrylate, polyterpene, nitroglycerin and optionally polyvinyl acetate
PCT/EP1999/002609 WO1999055327A1 (en) 1998-04-28 1999-04-19 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate

Publications (2)

Publication Number Publication Date
NO20005299D0 NO20005299D0 (en) 2000-10-20
NO20005299L true NO20005299L (en) 2000-10-20

Family

ID=7866045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005299A NO20005299L (en) 1998-04-28 2000-10-20 Composition containing polyacrylate, polyterpene, nitroglycerine and optional polyvinyl acetate

Country Status (8)

Country Link
EP (1) EP1079822A1 (en)
JP (1) JP2002512958A (en)
KR (1) KR20010043139A (en)
AU (1) AU3818499A (en)
CA (1) CA2330934A1 (en)
DE (1) DE19818955C2 (en)
NO (1) NO20005299L (en)
WO (1) WO1999055327A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008026A2 (en) * 2001-07-16 2003-01-30 Pneumoflex Systems, L.L.C. Apparatus for self-induced cough-cardiopulmonary resuscitation
DE10141650C1 (en) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713239A (en) * 1979-05-29 1987-12-15 Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr Antianginal film and method of treating ischemic heart disease
EP0059441A1 (en) * 1981-03-02 1982-09-08 Füssener Textil AG Bioactive agent on terpene/alpha-cetocarboxylic-acid basis
US4725272A (en) * 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5498418A (en) * 1991-06-10 1996-03-12 Schwarz Pharma Ag Nitroglycerine plaster and process for its production
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
JPH06321780A (en) * 1993-05-07 1994-11-22 Daikyo Yakuhin Kogyo Kk Nitroglycerin cataplasm and its production

Also Published As

Publication number Publication date
EP1079822A1 (en) 2001-03-07
AU3818499A (en) 1999-11-16
DE19818955A1 (en) 1999-11-11
CA2330934A1 (en) 1999-11-04
DE19818955C2 (en) 2000-06-29
NO20005299D0 (en) 2000-10-20
JP2002512958A (en) 2002-05-08
WO1999055327A1 (en) 1999-11-04
KR20010043139A (en) 2001-05-25

Similar Documents

Publication Publication Date Title
NO983019L (en) Method of Inhibiting Photo-aging of Skin
DK0858330T3 (en) Compositions containing derivatives of hydroperoxyeicosatetraenoic acid and methods of use in the treatment of disease
TR200002784T2 (en) Type 5 and type 3 17beta-Hydroxysteroid dehydrogenase inhibitors and methods for their use
DK154538C (en) PHARMACEUTICAL FOR TRANSDERMAL APPLICATION OF ACTIVE SUBSTANCES SUITABLE IN THE FORM OF A MOVIE OF A COPOLYMERIZATE OF METHYLIC AND / OR ETHYLESTERS OF ACRYLIC AND METHACRYLIC ACID, AND PROCEDURES FOR PREPARATION
ZA811428B (en) Adhesive suitable for application to skin
JPS53113008A (en) Constant rate releasing preparation
HUP0303923A2 (en) Combinations of sterol absorbtion inhibitor(s) with cardiovascular agents for treatment cardiovascular conditions and pharmaceutical compositions containing the combination
DE69033994D1 (en) Liquid polymer composition and method of using it
DE69329856D1 (en) ESTER DERIVATIVES OF 4-AZA STEROIDS
MXPA04006553A (en) 4-oxoquinoline compound and its use as hiv integrase inhibitor.
EA199800943A1 (en) UREA DERIVATIVES AND THEIR USE AS INHIBITORS INOSINE-5`-MONO-PHOSPHATE-DEHYDROGENASE INHIBITORS
BR9808109A (en) Therapeutic smooth muscle vascular cell inhibitor
MY138860A (en) Hiv protease inhibitors.
ATE128029T1 (en) TRANSDERMAL ESTRADIOL AS A THERAPEUTIC SYSTEM.
AU7371600A (en) Use of alpha-linolenic acid metabolites for treatment or prevention of cancer
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
NO950518L (en) Use of terpene compounds for reduced release of arachidonic acid and assay mediators
DK0527757T3 (en) Composition and method for treating acne vulgaris and delaying aging
IS4772A (en) Oral oral preparations with modified release containing 5-ASA.
WO2006039231A3 (en) Topical formulations for the treatment of depression with s adenosyl methionine
NO894222D0 (en) PROCEDURES FOR TREATING PROPHYLAXY OF PNEUMOCYTIS CARINII PNEUMONI AND OTHER DISEASES AND COMPOUNDS AND FORMULATIONS FOR USE IN THE ABOVE METHODS.
NO20005299L (en) Composition containing polyacrylate, polyterpene, nitroglycerine and optional polyvinyl acetate
JPS5218813A (en) Plasters for the relief of cutaneous diseases
NL7605675A (en) PROCEDURE FOR THE RESTORATION OF ACRYLIC OR METHACRYLIC ACID ESTERS.
KR987000088A (en) Composition and Method for Prevention and Treatment of HIV-1 Infection

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application